Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
128 studies found for:    Open Studies | "Shock, Septic"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Shock, Septic"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Effect of Albumin Administration on Vasopressor Duration in Resolving Septic Shock
Condition: Shock, Septic
Interventions: Drug: 25% Albumin;   Drug: Placebo
2 Recruiting Pilot Study: Echocardiographic and Hemodynamic Effects of Esmolol in Septic Shock Patients
Condition: Shock, Septic
Intervention: Drug: Esmolol
3 Not yet recruiting Effect of a Continuous Infusion of Esmolol on Stroke Volume in Patients With Hyperdynamic Vasoplegic Septic Shock
Condition: Shock, Septic
Interventions: Drug: Continuous perfusion of esmolol;   Drug: Continuous perfusion of saline
4 Not yet recruiting Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of 3 Doses of MOTREM in Patients With Septic Shock
Condition: Shock, Septic
Interventions: Drug: MOTREM;   Drug: Placebo
5 Not yet recruiting Treatment of Patients With Early Septic Shock and Bio-Adrenomedullin(ADM) Concentration > 70 pg/ml With ADRECIZUMAB
Condition: Septic Shock
Interventions: Biological: Adrecizumab;   Biological: Placebo
6 Recruiting Pilot Phase II Study: Hemodynamic Tolerance and Anti-inflammatory Effects of Esmolol During the Treatment of Septic Shock
Condition: Septic Shock
Intervention: Drug: Esmolol administration
7 Not yet recruiting PK/PD of Extended-infusion Meropenem, Piperacillin-tazobactam and Cefepime in the Early Phase of Septic Shock
Condition: Septic Shock
Interventions: Drug: MEROPENEM;   Drug: PIPERACILLIN-TAZOBACTAM;   Drug: CEFEPIME
8 Recruiting Administration of Hydrocortisone for the Treatment of Septic Shock
Condition: Septic Shock
Interventions: Drug: Hydrocortisone;   Drug: saline
9 Recruiting Esmolol Infusion for Patients With Septic Shock and Persistent Tachycardia
Condition: Septic Shock
Intervention: Drug: Esmolol
10 Recruiting Early Goal Directed Sedation on Microcirculation in Septic Shock
Condition: Septic Shock
Intervention: Drug: Dexmedetomidine for sedation
11 Recruiting A Randomized Controlled Study of Enteral Nutrition in Septic Shock
Condition: Septic Shock
Intervention: Other: Enteral nutrition
12 Recruiting Proadrenomedullin and Copeptin in Patients With Septic Shock
Condition: Septic Shock
Intervention:
13 Recruiting Anisodamine Critically Ill SeptIc Shock
Condition: Septic Shock
Intervention: Drug: anisodamine
14 Recruiting The Randomized Controlled Trial of Inferior Vena Cava Ultrasound-guided Fluid Management in Septic Shock Resuscitation
Condition: Septic Shock
Interventions: Procedure: IVC Ultrasound-guided;   Drug: Antibiotics;   Drug: Vasopressor
15 Recruiting Vasopressin Plasma Concentrations in Patients Receiving Exogenous Vasopressin Infusion for Septic Shock
Condition: Septic Shock
Intervention:
16 Recruiting Esmolol Effects on Heart and Inflammation in Septic Shock
Condition: Septic Shock
Intervention: Drug: Esmolol
17 Recruiting COMPACT 2 - COMbining Plasma-filtration and Adsorption Clinical Trial 2
Condition: Shock, Septic
Intervention: Device: High doses CPFA
18 Recruiting Plasmaexchange in Early Septic Shock
Condition: Septic Shock
Intervention: Device: Plasmaexchange
19 Recruiting Midodrine in the Recovery Phase of Septic Shock
Condition: Septic Shock
Interventions: Drug: midodrine;   Other: Standard of Care
20 Recruiting Study of Platelet Activation in Septic Shock Patients
Condition: Septic Shock
Interventions: Other: Septic choc group;   Other: Orthopedic surgery group

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.